-
急性脑梗死(acute cerebral infarction,ACI)是目前老年人常见的脑血管疾病,多由于脑组织局部供血不足导致缺血缺氧坏死而出现神经功能缺损,其致残、致死率均较高,给社会和病人家庭造成了严重的经济负担[1-2]。近期报道[3-4]发现,氧自由基是早期急性脑梗死缺血再灌注损伤加重的主要原因。依达拉奉能够有效清除体内增加的毒性氧自由基,是一种新型自由基清除剂[5];相关研究[6]已证实该药对改善急性脑梗死的神经功能缺损有较好的治疗作用。本研究选取60例急性脑梗死病人,均接受脑梗死常规治疗和重组组织纤溶酶原激活剂治疗,在此基础上观察组加用依达拉奉治疗,旨在观察依达拉奉对重组组织纤溶酶原激活剂治疗急性脑梗死病人期间氧自由基的清除作用。现作报道。
-
治疗前病人血清中的OH、NO及PLO水平差异均无统计学意义(P>0.05);治疗后,2组OH、NO及PLO水平均明显低于治疗前(P < 0.01),且观察组病人的血清OH、NO及PLO水平明显低于对照组(P < 0.01)(见表 1)。
分组 n OH NO PLO 治疗前 对照组 30 113.02±3.27 39.24±3.35 51.35±3.35 观察组 30 112.24±3.82 40.52±3.52 50.42±3.41 t — 0.83 1.44 1.06 P — >0.05 >0.05 >0.05 治疗后 对照组 30 56.87±3.32** 21.74±1.05** 18.24±2.65** 观察组 30 37.27±3.76** 12.26±1.98** 10.82±2.94** t — 21.40 23.17 10.26 P — <0.01 <0.01 <0.01 组内比较**P < 0.01 表 1 2组病人治疗前后OH、NO及PLO水平比较(nmol/mL)
-
治疗前病人血清中的SOD、AOPP及MDA水平差异无统计学意义(P>0.05);治疗后,2组SOD、AOPP及MDA水平均明显低于治疗前(P < 0.01),且观察组病人的血清SOD、AOPP及MDA水平明显低于对照组(P < 0.01)(见表 2)。
分组 n SOD/(U/mol) AOPP/(umol/L) MDA/(umol/L) 治疗前 对照组 30 177.52±26.64 111.45±12.08 9.38±1.15 观察组 30 178.21±27.22 112.56±11.57 9.41±1.21 t — 0.09 0.36 0.09 P — >0.05 >0.05 >0.05 治疗后 对照组 30 151.16±17.54** 90.76±9.15** 7.65±0.95** 观察组 30 116.87±16.78** 75.06±7.28** 5.80±0.74** t — 7.73 7.35 8.41 P — <0.01 <0.01 <0.01 组内比较**P < 0.01 表 2 2组病人治疗前后SOD、AOPP及MDA水平比较
-
治疗前病人ADL及NIHSS评分差异无统计学意义(P>0.05)。治疗后,2组ADL评分水平均明显高于治疗前(P < 0.01),NIHSS评分均低于治疗前(P < 0.01),且观察组ADL评分明显高于对照组(P < 0.01),而NIHSS评分明显低于对照组(P < 0.01)(见表 3)。
分组 n ADL评分 NIHSS评分 治疗前 对照组 30 28.54±4.26 21.72±2.66 观察组 30 27.61±4.35 22.61±2.27 t — 0.84 1.39 P — >0.05 >0.05 治疗后 对照组 30 51.13±6.23** 11.14±1.54** 观察组 30 40.87±7.79** 16.85±2.28** t — 5.63 11.37 P — <0.01 <0.01 组内比较**P < 0.01 表 3 2组病人ADL及NIHSS评分比较(x±s; 分)
依达拉奉对重组组织纤溶酶原激活剂治疗急性脑梗死病人期间氧自由基的清除作用
Scavenging effect of edaravone on oxygen free radical in acute cerebral infarction patients treated with recombinant tissue plasminogen activator
-
摘要:
目的观察依达拉奉治疗对重组组织纤溶酶原激活剂治疗急性脑梗死病人期间氧自由基的清除作用。 方法选择60例急性脑梗死病人,随机分为观察组和对照组,每组30例,所有病人均接受脑梗死常规治疗和重组组织纤溶酶原激活剂治疗,在此基础上观察组加用依达拉奉治疗。分别于治疗前后测定病人血清中羟基自由基(OH)、一氧化氮(NO)、过氧化脂质(PLO)、过氧化物歧化酶(SOD)、晚期氧化蛋白产物(AOPP)及丙二醛(MDA)的含量,并采用日常生活能力缺损评分(ADL)评定病人日常生活能力,采用神经功能缺损评分(NIHSS)量表评定神经功能缺损情况。 结果治疗前2组OH、NO、PLO、SOD、AOPP、MDA水平和ADL、NIHSS评分差异均无统计学意义(P>0.05)。治疗后,2组OH、NO及PLO水平均明显低于治疗前(P < 0.01),且观察组病人的血清OH、NO及PLO水平明显低于对照组(P < 0.01)。治疗后,2组病人血清中的SOD、AOPP及MDA水平均明显低于治疗前(P < 0.01),且观察组病人的血清SOD、AOPP及MDA水平明显低于对照组(P < 0.01)。治疗后2组病人的ADL评分均较治疗前明显增高(P < 0.01),且观察组的评分明显高于对照组(P < 0.01),而NIHSS评分均有降低(P < 0.01),且观察组的评分明显低于对照组(P < 0.01)。 结论在重组组织纤溶酶原激活剂治疗急性脑梗死病人的同时加用依达拉奉更能够有效清除氧自由基含量,减少氧化应激损伤,改善病人日常生活能力。 -
关键词:
- 脑梗死 /
- 重组组织型纤溶酶原激活剂 /
- 自由基清除剂 /
- 依达拉奉
Abstract:ObjectiveTo observe the scavenging effects of edaravone on oxygen free radical in acute cerebral infarction patients treated with recombinant tissue plasminogen activator. MethodsSixty patients with acute cerebral infarction were randomly divided into the observation group and control group(30 cases each group).All patients were treated with routine treatment method of cerebral infarction combined with recombinant tissue plasminogen activator, and the observation group were additionally treated with edaravone.The serum levels of Hydroxyl radical(OH), nitric oxide(NO), lipid peroxide(PLO), peroxide dismutase(SOD), advanced oxidative protein product(AOPP) and malondialdehyde(MDA) in two groups were measured before and after treatment.The daily living ability and neurological deficit in two groups were evaluated using ADL and NIHSS. ResultsBefore treatment, the differences of the levels of OH, NO, PLO, SOD, AOPP, MDA, ADL and NIHSS scores between two groups were statistically significant before treatment(P>0.05).After treatment, the levels of OH, NO and PLO in two groups were significantly lower than those before treatment(P < 0.01), and the serum levels of OH, NO and PLO in observation group were significantly lower than those in control group(P < 0.01).After treatment, the serum levels of SOD, AOPP and MDA in two groups were significantly lower than those before treatment(P < 0.01), and the serum levels of SOD, AOPP and MOD in observation group were significantly lower than those in control group(P < 0.01).After treatment, the ADL scores in two groups significantly increased compared before treatment(P < 0.01), and the ADL score in observation group were significantly higher than that in control group(P < 0.01).After treatment, the NIHSS scores in two groups decreased compared before treatment(P < 0.01), and the NIHSS score in observation group were significantly lower than that in control group(P < 0.01). ConclusionsThe recombinant tissue plasminogen activator combined with edaravone in the treatment of acute cerebral infarction can effectively scavenge oxygen free radical, reduce oxidative stress injury, and improve daily living ability. -
表 1 2组病人治疗前后OH、NO及PLO水平比较(nmol/mL)
分组 n OH NO PLO 治疗前 对照组 30 113.02±3.27 39.24±3.35 51.35±3.35 观察组 30 112.24±3.82 40.52±3.52 50.42±3.41 t — 0.83 1.44 1.06 P — >0.05 >0.05 >0.05 治疗后 对照组 30 56.87±3.32** 21.74±1.05** 18.24±2.65** 观察组 30 37.27±3.76** 12.26±1.98** 10.82±2.94** t — 21.40 23.17 10.26 P — <0.01 <0.01 <0.01 组内比较**P < 0.01 表 2 2组病人治疗前后SOD、AOPP及MDA水平比较
分组 n SOD/(U/mol) AOPP/(umol/L) MDA/(umol/L) 治疗前 对照组 30 177.52±26.64 111.45±12.08 9.38±1.15 观察组 30 178.21±27.22 112.56±11.57 9.41±1.21 t — 0.09 0.36 0.09 P — >0.05 >0.05 >0.05 治疗后 对照组 30 151.16±17.54** 90.76±9.15** 7.65±0.95** 观察组 30 116.87±16.78** 75.06±7.28** 5.80±0.74** t — 7.73 7.35 8.41 P — <0.01 <0.01 <0.01 组内比较**P < 0.01 表 3 2组病人ADL及NIHSS评分比较(x±s; 分)
分组 n ADL评分 NIHSS评分 治疗前 对照组 30 28.54±4.26 21.72±2.66 观察组 30 27.61±4.35 22.61±2.27 t — 0.84 1.39 P — >0.05 >0.05 治疗后 对照组 30 51.13±6.23** 11.14±1.54** 观察组 30 40.87±7.79** 16.85±2.28** t — 5.63 11.37 P — <0.01 <0.01 组内比较**P < 0.01 -
[1] WEN X, WANG Y, ZHANG F, et al.In vivo monitoring of neural stem cells after transplantation in acute cerebral infarction with dual-modal MR imaging and optical imaging[J].Biomaterials, 2014, 35(16):4627. doi: 10.1016/j.biomaterials.2014.02.042 [2] WU W, GUAN Y, XU K, et al.Plasma Homocysteine Levels Predict the risk of acute cerebral infarction in patients with carotid artery lesions[J].Mol Neurobiol, 2016, 53(4):2510. doi: 10.1007/s12035-015-9226-y [3] 王以翠.神经节苷脂对超急性期脑梗死患者脑缺血再灌注损伤的保护作用[J].兰州大学学报(医学版), 2015, 41(5):17. [4] HUA F, TANG H, WANG J, et al.TAK-242, an antagonist for Toll-like receptor 4, protects against acute cerebral ischemia reperfusion injury in mice[J].J CEREBR BLOOD F MET, 2015, 35(4):536. doi: 10.1038/jcbfm.2014.240 [5] TAKENAKA K, KATO M, YAMAUTI K, et al.Simultaneous administration of recombinant tissue plasminogen activator and edaravone in acute cerebral ischemic stroke patients.[J].J STROKE CEREBROVASC, 2014, 23(10):2748. doi: 10.1016/j.jstrokecerebrovasdis.2014.06.016 [6] 疏叶华.依达拉奉联合脑心通胶囊治疗急性脑梗死临床疗效观察[J].淮海医药, 2014, 32(5):442. [7] 中华医学会神经病学分会, 中华医学会神经病学分会脑血管病学组.中国急性缺血性脑卒中诊治指南2014[J].中华神经科杂志, 2015, 48(4):246. doi: 10.3760/cma.j.issn.1006-7876.2015.04.002 [8] HUANG Y H, XIA Z X, WEI W, et al.The impact of leucoaraiosis on neurological function recovery in elderly patients with acute cerebral infarction:Clinical study involving 279 Chinese patients[J].J Int Med Res, 2014, 42(3):1223. [9] 郭岩, 张翠宏, 王海洋等.伴心房颤动的急性脑梗死不同时间窗行重组组织型纤溶酶原激活剂静脉溶栓治疗的疗效观察[J].中华医学杂志, 2016, 96(26):2054. doi: 10.3760/cma.j.issn.0376-2491.2016.26.004 [10] KIZMAZOGLU C, AYDIN HE, SEVIN IE, et al.Neuroprotective Effect of Resveratrol on Acute Brain Ischemia Reperfusion Injury by Measuring Annexin V, p53, Bcl-2 Levels in Rats[J].J Korean Neurosurg Soc, 2015, 58(6):508. doi: 10.3340/jkns.2015.58.6.508 [11] 蒋娟莉, 张建.急性脑梗死介入治疗后应用丁苯酞联合依达拉奉改善神经功能恢复的临床研究[J].海南医学院学报, 2016, 22(16):1884. [12] LEE XR, XIANG GL.Effects of edaravone, the free radical scavenger, on outcomes in acute cerebral infarction patients treated with ultra-early thrombolysis of recombinant tissue plasminogen activator[J].Clin Neurol Neurosurg, 2018, 167:157. doi: 10.1016/j.clineuro.2018.02.026 [13] 薛小慧.依达拉奉对急性脑梗死病人氧自由基的清除效果及神经功能的影响[J].中西医结合心血管病电子杂志, 2018, 6(5):122.. doi: 10.3969/j.issn.2095-6681.2018.05.085 [14] WANG Y, YUAN L, LIU P, et al.Delayed hyperoxic ventilation attenuates oxygen-induced free radical accumulation during early reperfusion after global brain ischemia[J].Neuroreport, 2015, 26(3):131. doi: 10.1097/WNR.0000000000000314 [15] 刘昭淑, 周霞.早期康复训练联合依达拉奉对脑出血患者氧自由基生成、神经损伤程度的影响[J].海南医学院学报, 2017, 23(16):2282. [16] CAI J, CAO S, CHEN J, et al.Progesterone alleviates acute brain injury via reducing apoptosis and oxidative stress in a rat experimental subarachnoid hemorrhage model[J].Neurosci Lett, 2015, 600(1):238. [17] 陈冬丽, 汪显琪, 李江, 等.依达拉奉联合Rt-PA静脉溶栓对急性脑梗死病人氧化应激及自由基的影响[J].中西医结合心脑血管病杂志, 2017, 15(14):1775. doi: 10.3969/j.issn.1672-1349.2017.14.031